KAWAMOTO CORPORATION (E00614) Stock Price

Kawamoto Sangyo and its group companies provide a wide range of products and services in the medical and healthcare sectors. The group consists of six companies, including Kawamoto Sangyo, and primarily manufactures and sells hygiene materials, medical supplies, healthcare products, and safety protective equipment, as well as procures and sells these products. Additionally, Air Water Inc., the parent company of Kawamoto Sangyo, manufactures and sells industrial gases, chemical products, medical-related products, energy products, and agricultural and food products.

Kawamoto Sangyo Group's business is divided into two main segments: the "Medical Business" and the "Consumer Business." In the Medical Business, the group manufactures, sells, and procures hygiene materials, medical supplies, and healthcare products for medical institutions and facilities both domestically and internationally. This contributes to improved safety and hygiene in medical settings.

In the Consumer Business, the group manufactures, sells, and procures hygiene materials, medical supplies, healthcare products, childcare products, and safety protective equipment for domestic companies, general consumers, and industrial sectors. This contributes to improved quality of life and safety assurance in households and industrial workplaces.

Through these operations, Kawamoto Sangyo Group provides products and services that address a wide range of needs in the medical and healthcare sectors, contributing to society.

Kawamoto Sangyo aims to improve public health and enhance quality of life through the provision of products and services in the medical and healthcare sectors. Based on its management philosophy, the company has identified five key strategic priorities: shareholder value, customer-first approach, quality improvement, high-value-added product offerings, and sustainability initiatives.

As part of its medium to long-term management strategy, the company has designated eight priority areas: strengthening product development and sales systems based on consumer needs, rigorous quality control, rapid response to changes in the healthcare environment, development and cultivation of high-value-added products, stable distribution network reinforcement, production efficiency optimization, sustainability promotion, and response to COVID-19.

The company emphasizes collaborative development of specialized and differentiated high-value-added products with medical institutions and experts, strengthening relationships with nationwide distributors and authorized dealers to ensure distribution stability, and optimizing production systems across the group. Additionally, the company is advancing sustainability initiatives and addressing COVID-19 through development and expansion of infection control products, as well as workplace reforms.

Against this strategic backdrop, the Kawamoto Sangyo Group aims to contribute to society by providing a wide range of products and services that address diverse needs in the medical and healthcare sectors. The company recognizes product portfolio expansion and profit margin improvement as critical priorities, and is actively promoting sales of infection control products, oral care products, and care supplies, while developing new products that meet market needs and expanding contract manufacturing. The company also recognizes the importance of human capital and is actively investing in initiatives to enhance employee diversity and expertise, as well as developing next-generation management leaders.